TIPE2 and gastric cancer: Furthermore, TIPE2 suppressed the epithelial-mesenchymal transition (EMT) and metastasis of tumor cells via suppressing PI3K/Akt and Wnt/β-catenin signaling pathways in some tumor types, including glioma, gastric cancer and breast cancer (14–16).